COMPASS THERAPEUTICS, INC. Shareholders' Equity
COMPASS THERAPEUTICS, INC. (CMPX) had Shareholders' Equity of $166.05 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-08-06
- 2026-06-30: Stockholders' Equity Attributable to Parent $166.05M.
- 2026-03-31: Stockholders' Equity Attributable to Parent $186.47M.
- 2025-12-31: Stockholders' Equity Attributable to Parent $196.79M.
- 2025-09-30: Stockholders' Equity Attributable to Parent $209.61M.
| Period end | Stockholders' Equity Attributable to Parent | Stockholders' Equity Attributable to Parent as first filed |
|---|---|---|
| 2026-06-30 | $166.05M 10-Q · filed 2026-08-06 | |
| 2026-03-31 | $186.47M 10-Q · filed 2026-08-06 | |
| 2025-12-31 | $196.79M 10-Q · filed 2026-08-06 | |
| 2025-09-30 | $209.61M 10-Q · filed 2025-11-05 | |
| 2025-06-30 | $93.21M 10-Q · filed 2026-08-06 | |
| 2025-03-31 | $110.28M 10-Q · filed 2026-08-06 | |
| 2024-12-31 | $125.23M 10-Q · filed 2026-08-06 | |
| 2024-09-30 | $138.40M 10-Q · filed 2025-11-05 | |
| 2024-06-30 | $146.10M 10-Q · filed 2025-11-05 | |
| 2024-03-31 | $157.06M 10-Q · filed 2025-11-05 | |
| 2023-12-31 | $148.54M 10-K · filed 2026-03-05 | |
| 2023-09-30 | $160.04M 10-Q · filed 2024-11-12 | |
| 2023-06-30 | $168.29M 10-Q · filed 2024-11-12 | |
| 2023-03-31 | $175.26M 10-Q · filed 2024-11-12 | |
| 2022-12-31 | $181.64M 10-K · filed 2025-02-27 | |
| 2022-09-30 | $116.12M 10-Q · filed 2023-11-09 | |
| 2022-06-30 | $126.93M 10-Q · filed 2023-11-09 | |
| 2022-03-31 | $134.49M 10-Q · filed 2023-11-09 | |
| 2021-12-31 | $140.08M 10-K · filed 2024-03-21 | |
| 2021-09-30 | $23.89M 10-Q · filed 2022-11-09 | |
| 2021-06-30 | $28.88M 10-Q · filed 2022-11-09 | |
| 2021-03-31 | $33.47M 10-Q · filed 2022-11-09 | |
| 2020-12-31 | $39.95M 10-K · filed 2023-03-15 | |
| 2020-09-30 | $47.29M 10-Q · filed 2021-11-12 | |
| 2020-06-30 | $53.25M 10-Q · filed 2021-11-12 | |
| 2020-03-31 | -$124.76M 10-Q · filed 2021-11-12 | -$108.07K 10-K · filed 2020-06-08 |
| 2019-12-31 | $11.27M 10-K · filed 2022-03-18 | -$102.14K 10-Q · filed 2020-02-14 |
| 2019-09-30 | -$112.22M 10-Q · filed 2020-11-09 | -$90.45K 10-Q · filed 2019-11-13 |
| 2019-06-30 | -$103.91M 10-Q · filed 2020-11-09 | -$82.05K 10-Q · filed 2019-08-13 |
| 2019-03-31 | -$95.29M 10-Q · filed 2020-11-09 | -$70.59K 10-K · filed 2019-07-01 |
| 2018-12-31 | -$84.77M 10-K · filed 2021-03-05 | -$61.72K 10-Q · filed 2019-02-14 |
| 2018-09-30 | -$51.58K 10-Q · filed 2018-11-14 | |
| 2018-06-30 | -$43.03K 10-Q · filed 2018-08-14 | |
| 2018-03-31 | -$34.55K 10-K · filed 2020-06-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| ANAVEX LIFE SCIENCES CORP. (AVXL) | United States | $0.218B | -18.37 |
| Protalix BioTherapeutics, Inc. (PLX) | $0.221B | 9.87 | |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |
| Aligos Therapeutics, Inc. (ALGS) | United States | $0.238B | -0.47 |
| Lineage Cell Therapeutics, Inc. (LCTX) | United States | $0.241B | -10.35 |